Malignant struma ovarii: presentation and management
| Autor: | Cyril Fisher, Clive Harmer, M. E. A. O'Connell |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Adult
Ovarian Neoplasms Gynecology medicine.medical_specialty Struma ovarii business.industry Thyroid Gland General Medicine Malignant Struma Ovarii Adenocarcinoma medicine.disease Struma Ovarii Surgery Iodine Radioisotopes medicine Humans Female Radiology Nuclear Medicine and imaging Primary treatment Surgical excision business |
| Zdroj: | The British Journal of Radiology. 63:360-363 |
| ISSN: | 1748-880X 0007-1285 |
| DOI: | 10.1259/0007-1285-63-749-360 |
| Popis: | Struma ovarii are rare tumours and just over 400 cases are reported in the world literature (Gould et al, 1983). The incidence of malignancy is reported as 5–10% of all cases of struma ovarii (Marcus & Marcus, 1961) but has been reported as less (Gould et al, 1983). The metastasis rate is estimated to be 5–6% (Emge, 1940) and only 21 cases with metastases have so far been reported (Dalley, 1970; Pardo-Mindan & Vazquez, 1983; Willemse et al, 1987; Rosenblum et al, 1989). Owing to their rarity, there is no universal agreement as to management. Surgical excision continues to remain the initial definitive primary treatment. However, metastatic and recurrent malignant struma ovarii have been treated with radioactive 131I (Woodruff et al, 1966; Kempers et al, 1970; Willemse et al, 1987). Intra-peritoneal radiocolloids (Woodruff et al, 1966; Rosenblum et al, 1989) and external beam radiotherapy (Gonzalez-Angulo et al, 1963; Woodruff et al, 1966; Pardo-Mindan & Vazquez, 1983) have also found a useful role in pall... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|